ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    South Asian and Muslim Canadian Patients Are Less Likely to Receive Living Donor Kidney Transplant Offers Compared to Caucasian, Non-Muslim Patients

    A. Ali,1 A. Ayub,1 C. Richardson,1 N. Edwards,1 T. Ahmed,1 M. Novak,2,3 I. Mucsi.1

    1Multi-Organ Transplant Program, Toronto General Hospital, Toronto, ON, Canada; 2Centre for Mental Health, University Health Network, Toronto, ON, Canada; 3Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

    Background:No studies have assessed whether Muslim Canadians face barriers to accessing LDKT. We explored how frequently Muslim or South Asian patients with and stage kidney…
  • 2018 American Transplant Congress

    Attitudes of African Canadian Patients with End Stage Kidney Disease toward Living Donor Kidney Transplantation

    V. Gupta, C. Richardson, D. Belenko, N. Singh, A. Xu, P. Thiagalingam, D. Wong, H. Ford, M. Novak, I. Mucsi.

    University Health Network, Toronto, ON, Canada.

    Background:African Canadian patients with end stage kidney disease (ESKD) are less likely to receive a living donor kidney transplant (LDKT) compared to Caucasian Canadians. We…
  • 2018 American Transplant Congress

    How Old is Too Old? Expanding Living Kidney Organ Transplantation from Donors above 60 Years of Age with Associated Comorbidity.

    A. Ghazanfar, L. Salih.

    Transplant Surgery, St Georges University Hospital NHS Foundation Trust, London, United Kingdom.

    Background: Worldwide the population is ageing. In UK there are more people above 60 than under 16 years of age. Hence there are more elderly…
  • 2018 American Transplant Congress

    Shortening Length of Post-Operative In-Patient Stay for Living Kidney Donors

    M. Loiselle, H. Bruschwein, J. Jacobs, S. Gulin, T. Rose, H. Arora, R. Nash, A. Toledo, T. Kozlowski.

    Department of Surgery, University of North Carolina, Chapel Hill.

    Purpose. The study analyzes the impact of psychiatric history on postoperative length of hospital stay (LOS) of living kidney donors (LD) and initial assessment of…
  • 2018 American Transplant Congress

    The New Crescentic Incision: A Good Option for Donor Nephrectomy

    M. Haberal,1 M. Kirnap,1 A. Akdur,1 E. Ayvazoglu Soy,1 S. Yildirim,1 G. Moray,1 Z. Kayhan,2 A. Torgay.2

    1Transplantation, Baskent University, Ankara, Turkey; 2Anesthesiology, Baskent University, Ankara, Turkey.

    Introduction: Living kidney donation helps to avoid or reduce the time period of dialysis and time spent on waiting lists for patients requiring a new…
  • 2018 American Transplant Congress

    Transplantation of Restored Kidneys from Living Related Donors after Small Renal Tumor Resection: Report of 5 Cases

    Y. Ogawa,1 S. Shiroma,2 K. Kojima,2 R. Mannami,2 M. Mannami,2 N. Mitsuhata,2 M. Nishi,4 H. Afuso.3

    1Urology, Tokyo-West Tokushukai Hospital, Akishima, Tokyo, Japan; 2Urology, Uwajima Toikushukai Hospital, Uwajima, Ehime, Japan; 3Urology, Okinawa Chubu Tokushukai Hospital, Okinawa, Japan; 4Urology, Saint Martin's Hospital, Sakaide, Kagawa, Japan.

    Purpose: We launched a clinical trial registered at ClinicalTrials.gov that aimed to study the utility and safety of restored kidney transplantation between family members using…
  • 2018 American Transplant Congress

    Impact of AB0-Incompatible Kidney Transplantation on Lymphocele Formation

    C. Salabe,1 S. Zschiedrich,2 P. Pisarski,1 B. Jänigen.1

    1Department of General and Digestive Surgery, Section of Transplant Surgery, University Medical Center Freiburg, Freiburg, Germany; 2Renal Division, Department of Medicine, University Medical Center Freiburg, Freiburg, Germany.

    C Salabe1, S Zschiedrich2, P Pisarski1, BM Jänigen11 Department of General and Digestive Surgery, Section of Transplant Surgery, University Medical Centre Freiburg, Freiburg, Germany2 Renal…
  • 2018 American Transplant Congress

    Experience and Safety of Hand-Assisted Laparoscopic Nephrectomy for Living Kidney Donors at Mexico´s General Hospital "Dr. Eduardo Liceaga"

    P. Prieto-Olivares, L. Garcia-Covarrubias, A. Bahena-Portillo, A. Cicero-Lebrija, V. Visag-Castillo, H. Hinojosa-Heredia, D. Fernandez-Angel, Y. Carrión, A. Rosas, E. Pedraza, I. Castro, A. García-Covarrubias, H. Diliz-Perez.

    Organ Transplantation, Hospital General de Mexico "Dr. Eduardo Liceaga", Mexico City, Mexico.

    Background: Hand-assisted laparoscopic nephrectomy (HALN) is the procedure of choice for living kidney donors. Our center is a public hospital that serves low-income patients from…
  • 2018 American Transplant Congress

    Analysis of Patient Reported Outcomes for Patients That Received Living Donor Kidney Transplants

    E. Venniro,1,2 J. Taylor.1,2

    1Center for Transplantation, University of Rochester Medical Center, Rochester, NY; 2Division of Nephrology, University of Rochester Medical Center, Rochester, NY.

    Purpose: Caring for subjective complaints is one of the most difficult aspects of any health care provider's job. These conditions in the transplant patient are…
  • 2018 American Transplant Congress

    Further In Vivo and In Vitro Evidence That Anti-CD40 MABS Do Not Induce Thromboembolism

    T. Rubic-Schneider, B. Christen, N. Runser Loll, D. Garcia, E. Erard, T. Flandre, B. Cochin de Billy, S. Nock, S. Côté, J. Rush, P. Ulrich.

    Novartis Institutes for Biomedical Research, Basel, Switzerland.

    Clinical trials with non-silenced anti-CD40L (anti-CD154) monoclonal antibodies (mAb) in patients with systemic lupus erythematosus (SLE) and idiopathic thrombocytopenic purpura (ITP) were halted after unexpected…
  • « Previous Page
  • 1
  • …
  • 765
  • 766
  • 767
  • 768
  • 769
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences